These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31871087)

  • 1. β-Lactamase of Mycobacterium tuberculosis Shows Dynamics in the Active Site That Increase upon Inhibitor Binding.
    Elings W; Gaur A; Blok AJ; Timmer M; van Ingen H; Ubbink M
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis.
    Tassoni R; Blok A; Pannu NS; Ubbink M
    Biochemistry; 2019 Feb; 58(7):997-1009. PubMed ID: 30632739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.
    Egesborg P; Carlettini H; Volpato JP; Doucet N
    Protein Sci; 2015 Apr; 24(4):534-44. PubMed ID: 25492589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphate Promotes the Recovery of Mycobacterium tuberculosis β-Lactamase from Clavulanic Acid Inhibition.
    Elings W; Tassoni R; van der Schoot SA; Luu W; Kynast JP; Dai L; Blok AJ; Timmer M; Florea BI; Pannu NS; Ubbink M
    Biochemistry; 2017 Nov; 56(47):6257-6267. PubMed ID: 29087696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the covalent adduct formed between Mycobacterium tuberculosis beta-lactamase and clavulanate.
    Tremblay LW; Hugonnet JE; Blanchard JS
    Biochemistry; 2008 May; 47(19):5312-6. PubMed ID: 18422342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations.
    Kurz SG; Wolff KA; Hazra S; Bethel CR; Hujer AM; Smith KM; Xu Y; Tremblay LW; Blanchard JS; Nguyen L; Bonomo RA
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6085-96. PubMed ID: 24060876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics.
    Elings W; Chikunova A; van Zanten DB; Drenth R; Ahmad MUD; Blok AJ; Timmer M; Perrakis A; Ubbink M
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0262820. PubMed ID: 34031049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NXL104 irreversibly inhibits the β-lactamase from Mycobacterium tuberculosis.
    Xu H; Hazra S; Blanchard JS
    Biochemistry; 2012 Jun; 51(22):4551-7. PubMed ID: 22587688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif.
    Soroka D; Li de la Sierra-Gallay I; Dubée V; Triboulet S; van Tilbeurgh H; Compain F; Ballell L; Barros D; Mainardi JL; Hugonnet JE; Arthur M
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5714-20. PubMed ID: 26149997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toho-1 β-lactamase: backbone chemical shift assignments and changes in dynamics upon binding with avibactam.
    Sakhrani VV; Ghosh RK; Hilario E; Weiss KL; Coates L; Mueller LJ
    J Biomol NMR; 2021 Sep; 75(8-9):303-318. PubMed ID: 34218390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.
    Wang F; Cassidy C; Sacchettini JC
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2762-71. PubMed ID: 16870770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of β-lactamase inhibition on the activity of ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus.
    Dubée V; Soroka D; Cortes M; Lefebvre AL; Gutmann L; Hugonnet JE; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2015 May; 59(5):2938-41. PubMed ID: 25733512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of β-lactamases of mycobacteria by avibactam and clavulanate.
    Soroka D; Ourghanlian C; Compain F; Fichini M; Dubée V; Mainardi JL; Hugonnet JE; Arthur M
    J Antimicrob Chemother; 2017 Apr; 72(4):1081-1088. PubMed ID: 28039278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal Structure of Phosphoserine BlaC from
    Moural TW; White DS; Choy CJ; Kang C; Berkman CE
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269656
    [No Abstract]   [Full Text] [Related]  

  • 15. Directed evolution of Mycobacterium tuberculosis β-lactamase reveals gatekeeper residue that regulates antibiotic resistance and catalytic efficiency.
    Feiler C; Fisher AC; Boock JT; Marrichi MJ; Wright L; Schmidpeter PA; Blankenfeldt W; Pavelka M; DeLisa MP
    PLoS One; 2013; 8(9):e73123. PubMed ID: 24023821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures of the Michaelis complex (1.2 Å) and the covalent acyl intermediate (2.0 Å) of cefamandole bound in the active sites of the Mycobacterium tuberculosis β-lactamase K73A and E166A mutants.
    Tremblay LW; Xu H; Blanchard JS
    Biochemistry; 2010 Nov; 49(45):9685-7. PubMed ID: 20961112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search for non-lactam inhibitors of mtb β-lactamase led to its open shape in apo state: new concept for antibiotic design.
    Sagar A; Haleem N; Bashir YM; Ashish
    Sci Rep; 2017 Jul; 7(1):6204. PubMed ID: 28740144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study.
    Krishnan NP; Nguyen NQ; Papp-Wallace KM; Bonomo RA; van den Akker F
    PLoS One; 2015; 10(9):e0136813. PubMed ID: 26340563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic and Structural Characterization of the Interaction of 6-Methylidene Penem 2 with the β-Lactamase from Mycobacterium tuberculosis.
    Hazra S; Kurz SG; Wolff K; Nguyen L; Bonomo RA; Blanchard JS
    Biochemistry; 2015 Sep; 54(36):5657-64. PubMed ID: 26237118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR characterization of the metallo-beta-lactamase from Bacteroides fragilis and its interaction with a tight-binding inhibitor: role of an active-site loop.
    Scrofani SD; Chung J; Huntley JJ; Benkovic SJ; Wright PE; Dyson HJ
    Biochemistry; 1999 Nov; 38(44):14507-14. PubMed ID: 10545172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.